Coronary/Structural Heart

Dassault Systèmes’ Living Heart Project Reaches Next Milestones in Mission to Improve Patient Care

HOLLYWOOD, Fla.–(BUSINESS WIRE)–Dassault Systèmes (Paris:DSY) (Euronext Paris: #13065, DSY.PA) today outlined, at the 3DEXPERIENCE Forum North America, multiple milestones in its Living Heart Project aimed to drive the creation and use of simulated 3D personalized hearts in the treatment, diagnosis and prevention of heart diseases. As the scientific and medical community seeks faster and more targeted […]

The Aging Population of Cardiologists and Potential Solutions

By Ken Dropiewski, Prime-Core Executive Search ( According to MedAxiom’s annual Cardiovascular Provider Compensation & Production survey 45 percent of all cardiologists in America are aged 56 or older and 20 percent over 61. So, with an aging population of cardiology practitioners we must ask, “how is this is being addressed?” Two […]

Creavo Medical Technologies secures U.S. FDA 510(k)

October 16, 2017 Rebecca Anderson Technology has the potential to revolutionise emergency department triage of chest pain patients. Developer of innovative medical diagnostic technology, Creavo Medical Technologies, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The move opens the U.S. market for its portable scanning device, Vitalscan, […]

Baylis Medical and Siemens Healthineers co-sponsor physician training for state-of-the art, minimally invasive heart procedure

TORONTO, Oct. 17, 2017 /PRNewswire/ – Baylis Medical Company Inc. and Siemens Healthineers are co-sponsoring a first-of-its kind training program aimed at helping cardiologists perform a complex procedure that is quickly becoming the gold standard for treating patients with atrial fibrillation and other structural heart diseases. The two companies are working with […]

Study of Patients with Kidney Disease post TAVR

Study Evaluates Patients With Kidney Disease After Undergoing TAVR By Cardiac Interventions Today October 16, 2017—The American College of Cardiology (ACC) announced the publication of a study demonstrating a relatively low rate of patients with chronic kidney disease undergoing transcatheter aortic valve replacement (TAVR) who eventually need to start dialysis. […]

REVA Announces Commercial Expansion and the First Implant of the Fantom Bioresorbable Scaffold in Switzerland

SAN DIEGO, Oct. 16, 2017 (GLOBE NEWSWIRE) — REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) announced today the commercial expansion of its bioresorbable scaffold (“BRS”), Fantom®, with the first implant in Switzerland. The first implant of Fantom in Switzerland was conducted at Kantonsspital Baselland in Liestal, Switzerland by Dr. Gregor Leibundgut. “Following my […]

BIOLIFE4D Appoints Texas Heart Institute Surgeon Dr. Jeffrey Morgan Chief Medical Officer, Bolstering Leadership Team

CHICAGO, Oct. 13, 2017 /PRNewswire/ — Bioprinting startup BIOLIFE4D named accomplished thoracic and cardiac surgeon Jeffrey Morgan M.D., FACS, FACC as Chief Medical Officer, further bolstering its world-class leadership team. BIOLIFE4D is a pioneering biotech company focused on leveraging advances in life sciences and tissue engineering to 3D bioprint a viable human heart suitable for transplant. Joining […]

Elixir Medical Corporation to Unveil Game-Changing DynamXTM Metallic Stent at the 29th Transcatheter Cardiovascular Therapeutics Conference

MILPITAS, Calif.–(BUSINESS WIRE)–Elixir Medical Corporation, a leader in the development of breakthrough adaptive remodeling technologies designed to mimic the normal arterial function after cardiovascular and peripheral vascular disease intervention, announced today it will unveil a game-changing metallic drug eluting stent (DES) platform at this year’s Transcatheter Cardiovascular Therapeutics (TCT) conference […]

The Ethical Quandary of LVAD Disconnection

By Ken Dropiewski, Prime-Core Executive Search ( New research brings to light a question of ethics when it comes to the deactivation of a left ventricular assist device (LVAD). Concerns differ significantly between cardiologists, hospice, and palliative medicine clinicians. This has lead to inconsistent and confusing end-of-life care for some […]

HeartStitch® GmbH Announces NobleStitch™ EL Closure Data Compared to Published PFO Clinical Trials “RESPECT” and “CLOSURE” in New England Journal of Medicine

FRANKFURT, Germany, Oct. 6, 2017 /PRNewswire/ — Prof. Dr. Achille Gaspardone, Director of Cardiology at Hospital of Sant’Eugenio (Rome, Italy) presented a comprehensive report on closure of PFO (Patent Foramen Ovale) utilizing the NobleStitch™ EL suture based closure system at the CSI-UCSF meeting on Congenital Structural Interventions in San Francisco.  The NobleStitch™ EL, […]